Features:

• Pristine+™ elutes Everolimus drug which is most preferred drug by most of the interventional cardiologists
• The basic stent platform for Pristine+™ is L605 Cobalt Chromium stent
• The strut thickness for Pristine+TM is 60 μm
• Pristine+TM displays minimum recoil and excellent radial strength contributed by its unique open and closed cell stent design and strut locking mechanism
• Pristine+™ comes with rapid exchange Delivery System which enchances its efficacy
• Uniform Everolimus Coating thickness and precise in Everolimus Drug Release Kinetics as 95 +/- 5% of Everolimus is released within 120 days
• Hydrophilic Coated Stent Delivery System
• Designed for utmost safety – Pristine+™ displays one of the lowest entry profiles
• Completely biodegradable, biocompatible polymer (PLGA carrier) – Loading density of 1.0μg/mm²